Skip to main content

MoneyWorks4Me

Astrazeneca Pharma India informs about updates

20 Jan 2024 Evaluate
Astrazeneca Pharma India has informed that AstraZeneca Pharma India has received permission to Import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for Andexanet alfa powder for solution for infusion 200mg (Andexxa).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..